Glucocorticoid activation by 11β-hydroxysteroid dehydrogenase enzymes in relation to inflammation and glycaemic control in chronic kidney disease: A cross-sectional study.


Journal

Clinical endocrinology
ISSN: 1365-2265
Titre abrégé: Clin Endocrinol (Oxf)
Pays: England
ID NLM: 0346653

Informations de publication

Date de publication:
01 2019
Historique:
received: 13 08 2018
revised: 02 10 2018
accepted: 22 10 2018
pubmed: 26 10 2018
medline: 18 3 2020
entrez: 26 10 2018
Statut: ppublish

Résumé

Patients with chronic kidney disease (CKD) have dysregulated cortisol metabolism secondary to changes in 11β-hydroxysteroid dehydrogenase (11β-HSD) enzymes. The determinants of this and its clinical implications are poorly defined. We performed a cross-sectional study to characterize shifts in cortisol metabolism in relation to renal function, inflammation and glycaemic control. Systemic activation of cortisol by 11β-HSD was measured as the metabolite ratio (tetrahydrocortisol [THF]+5α-tetrahydrocortisol [5αTHF])/tetrahydrocortisone (THE) in urine. The cohort included 342 participants with a median age of 63 years, median estimated glomerular filtration rate (eGFR) of 28 mL/min/1.73 m In summary, glucocorticoid activation by 11β-HSD in our cohort comprising a spectrum of renal function was associated with inflammation and impaired glucose control.

Identifiants

pubmed: 30358903
doi: 10.1111/cen.13889
pmc: PMC6334281
doi:

Substances chimiques

Blood Glucose 0
Glucocorticoids 0
Glycated Hemoglobin A 0
hemoglobin A1c protein, human 0
C-Reactive Protein 9007-41-4
11-beta-Hydroxysteroid Dehydrogenases EC 1.1.1.146
Hydrocortisone WI4X0X7BPJ

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

241-249

Subventions

Organisme : Department of Health
Pays : United Kingdom
Organisme : Arthritis Research UK
ID : 20843
Pays : United Kingdom
Organisme : Versus Arthritis
ID : 20843
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 105479/Z/14/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P021220/1
Pays : United Kingdom

Informations de copyright

© 2018 The Authors. Clinical Endocrinology Published by John Wiley & Sons Ltd.

Références

Science. 2001 Dec 7;294(5549):2166-70
pubmed: 11739957
Proc Natl Acad Sci U S A. 2014 Mar 11;111(10):3817-22
pubmed: 24569863
Physiol Rev. 2013 Jul;93(3):1139-206
pubmed: 23899562
Ann Rheum Dis. 2008 Sep;67(9):1204-10
pubmed: 18420938
Clin Endocrinol (Oxf). 2019 Jan;90(1):241-249
pubmed: 30358903
J Clin Endocrinol Metab. 2008 Feb;93(2):550-6
pubmed: 17986636
Kidney Int. 1998 May;53(5):1343-7
pubmed: 9573550
Eur J Endocrinol. 2014 Jul;171(1):47-57
pubmed: 24743397
J Pathol. 2016 Dec;240(4):472-483
pubmed: 27578244
J Biomed Biotechnol. 2012;2012:691369
pubmed: 22919275
Diabetes. 2009 Nov;58(11):2506-15
pubmed: 19675138
Arthritis Rheum. 2012 Jul;64(7):2404-13
pubmed: 22294469
J Clin Endocrinol Metab. 1985 May;60(5):848-54
pubmed: 3980669
Arthritis Res Ther. 2015 May 14;17:121
pubmed: 25971255
J Clin Endocrinol Metab. 2012 Oct;97(10):3622-9
pubmed: 22872687
Calcif Tissue Int. 2011 Sep;89(3):246-51
pubmed: 21695543
Am J Physiol Renal Physiol. 2016 Dec 1;311(6):F1087-F1108
pubmed: 27707707
Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4111-6
pubmed: 21325058
Eur J Endocrinol. 2005 Aug;153(2):291-9
pubmed: 16061836
Clin J Am Soc Nephrol. 2012 Apr;7(4):588-94
pubmed: 22383749
Diabetes Obes Metab. 2011 Jun;13(6):498-504
pubmed: 21272190
J Am Soc Nephrol. 2005 Nov;16(11):3411-7
pubmed: 16207824
Vitam Horm. 1999;57:249-324
pubmed: 10232052
Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):E2482-91
pubmed: 24889609
Nephron. 1984;37(3):160-5
pubmed: 6738767
Pituitary. 2015 Apr;18(2):188-94
pubmed: 25724314
Metabolism. 2001 Jul;50(7):801-4
pubmed: 11436185
Clin J Am Soc Nephrol. 2012 Dec;7(12):1938-46
pubmed: 23024164
J Clin Endocrinol Metab. 2011 Dec;96(12):3775-84
pubmed: 21917861
Am J Physiol Gastrointest Liver Physiol. 2016 Jun 1;310(11):G952-61
pubmed: 27056725
Am J Hypertens. 2008 Jun;21(6):644-9
pubmed: 18443572
J Am Soc Nephrol. 2013 Feb;24(2):302-8
pubmed: 23362314
Lancet Diabetes Endocrinol. 2017 Jun;5(6):431-437
pubmed: 28365411
BMC Nephrol. 2013 Apr 25;14:95
pubmed: 23617441
J Endocrinol Invest. 2003 Jul;26(7):609-15
pubmed: 14594109
Arthritis Res Ther. 2006;8(4):R108
pubmed: 16846535
J Clin Endocrinol Metab. 2003 Jun;88(6):2738-44
pubmed: 12788882
Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14924-9
pubmed: 9405715
J Clin Endocrinol Metab. 2002 Jan;87(1):277-85
pubmed: 11788660
J Ren Nutr. 2008 Jan;18(1):70-5
pubmed: 18089448
Clin Endocrinol (Oxf). 2010 Nov;73(5):566-72
pubmed: 20550533
Ann Rheum Dis. 2015 Feb;74(2):464-9
pubmed: 24385202
J Clin Endocrinol Metab. 2016 Dec;101(12):4743-4751
pubmed: 27715400
Diabetes Care. 2010 Jul;33(7):1516-22
pubmed: 20413513
J Psychosom Res. 2006 Feb;60(2):145-53
pubmed: 16439267
Mol Cell Endocrinol. 2009 Mar 25;301(1-2):104-8
pubmed: 19022342

Auteurs

Michael S Sagmeister (MS)

Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Department of Renal Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Angela E Taylor (AE)

Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.

Anthony Fenton (A)

Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Department of Renal Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Nadezhda A Wall (NA)

Institute of Clinical Sciences, University of Birmingham, Birmingham, UK.

Dimitrios Chanouzas (D)

Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Department of Renal Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Peter G Nightingale (PG)

Institute of Translational Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Charles J Ferro (CJ)

Department of Renal Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Wiebke Arlt (W)

Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.

Paul Cockwell (P)

Department of Renal Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Rowan S Hardy (RS)

Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
Institute of Inflammation and Ageing, ARUK Rheumatoid Arthritis Centre of Excellence, and MRC ARUK Centre for Musculoskeletal Ageing, University of Birmingham, Birmingham, UK.

Lorraine Harper (L)

Department of Renal Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Institute of Clinical Sciences, University of Birmingham, Birmingham, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH